Xenbase Image ID: 144362

Figure S2. Inhibition of Xfz5 Function Is Dependent upon Morpholino Concentration When 10 ng of Xfz5 MO is used, Xdelta-1 expression recovers by stage 25 (E) with expression levels similar to control (A). This dose results in a smaller eye at stage 41 (F). However, when 20 ng of Xfz5 MO is used, Xdelta-1 expression is still absent at stage 25 (G) and results in a near complete loss of the eye at stage 41 (H). (A–D) uninjected control; (E–H) Xfz5 MO-injected side. Image published in: Van Raay TJ et al. (2005) Copyright © 2005. This image is reproduced with permission of the publisher and the copyright holder. This is an Open Access article distributed under the terms of the Creative Commons Attribution License. Larger Image Printer Friendly View

Return to previous page